Blood Cleansing with Oxiris for Septic Shock
Part of Infections clinical trials.
This study tests a special blood filter (Oxiris) to see if it helps clean the blood in people with septic shock. If you are receiving blood purification therapy, this filter might help your body recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must have septic shock (a severe infection causing very low blood pressure).
- Your doctor must have decided that you need blood cleansing therapy (like continuous kidney dialysis).
- You cannot have a 'Do Not Resuscitate' order or be expected to live less than 24 hours.
- You cannot be pregnant or breastfeeding.
- You must not be allergic to the filter materials (like heparin or certain plastics).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests a special blood-filtering device (OXiris) for people with severe abdominal infections that cause septic shock and kidney damage. It aims to see if this treatment can help control the infection and improve recovery.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.